BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2200658)

  • 1. Bartter's syndrome associated with indirect hyperbilirubinemia: a possible clinical variety.
    Cugini P; Sasaki H; Kawasaki T; Di Simone S; Di Palma L; Battisti P; Uezono K
    Endocrinol Jpn; 1990 Feb; 37(1):159-64. PubMed ID: 2200658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value and limitations of indomethacin in the treatment of Bartter's syndrome].
    Dequiedt P; Lefebvre J; Raviart B; Vanhille P; Lepoutre E; Lelièvre G; Tacquet A
    J Urol Nephrol (Paris); 1977 Sep; 83(9):688-93. PubMed ID: 926230
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bartter's syndrome. Failure of aspirin and success of indomethacin].
    Jáuregui WO; Di Fonzo P; Marchissio ML; Roehr E; Hauger-Klevene JH
    Medicina (B Aires); 1979; 39(4):447-56. PubMed ID: 397398
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis.
    Ohlsson A; Sieck U; Cumming W; Akhtar M; Serenius F
    Acta Paediatr Scand; 1984 Nov; 73(6):868-74. PubMed ID: 6395627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Bartter's syndrome with indomethacin.
    Garin EH; Fennell RS; Iravani A; Richard GA
    Am J Dis Child; 1980 Mar; 134(3):258-61. PubMed ID: 6767392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bartter's syndrome. Differentiation into two clinical groups.
    Robson WL; Arbus GS; Balfe JW
    Am J Dis Child; 1979 Jun; 133(6):636-8. PubMed ID: 35973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronization by indomethacin of the circadian rhythm of blood renin and aldosterone in a case of Bartter's syndrome].
    Cugini P; Lucia P; Murano G; Letizia C; Panichi G; Adone G; Vetere AM; Magnanelli S
    Minerva Urol Nefrol; 1985; 37(1):23-7. PubMed ID: 3901335
    [No Abstract]   [Full Text] [Related]  

  • 12. A case report of pseudohypoparathyroidism (Drezner's type I) associated with probable Bartter's syndrome.
    Iba K; Morii H; Wada M; Yasumoto R; Kishimoto T; Mitsuhashi T; Hojo K; Okahara T
    Endocrinol Jpn; 1981 Oct; 28(5):595-604. PubMed ID: 7047153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bartter's syndrome].
    Linnanvuo-Laitinen M; Pirttiaho H; Huttunen K; Viinikka L
    Duodecim; 1985; 101(20):1983-6. PubMed ID: 4085359
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymptomatic Bartter's syndrome.
    Barbour GL; Day JO
    South Med J; 1978 Nov; 71(11):1341-4, 1349. PubMed ID: 715482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
    Cordone G; Fasce L; Gianfranceschi P; Delucchi M; Iester A; Torcia R
    Minerva Pediatr; 1978 Jul; 30(13):1097-104. PubMed ID: 672851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin for Bartter's syndrome.
    Zancan L; Zacchello F; Mantero F
    Lancet; 1976 Dec; 2(7999):1354. PubMed ID: 63823
    [No Abstract]   [Full Text] [Related]  

  • 20. Escape from sodium and potassium retaining actions of aspirin-like drugs used in a patient with Bartter's syndrome.
    Ishikawa Y; Wada T
    Jpn Circ J; 1979 Aug; 43(8):757-67. PubMed ID: 501898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.